PQ-110-001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PQ-110-001, covering 2023-01-04 to 2023-01-04. Get the full timeline:
Most recent: Clinical Trial Update: Extension Study to Study PQ-110-001 (NCT03140969) [Phase 1, Phase 2]